28 March 2019 - One notion proposed by the Trump administration to blunt the rising cost of medicines is to require drug makers to disclose list — or wholesale — prices in their TV advertising. 

The hope is that companies will be persuaded to compete on price if “relevant information” is provided. But the idea has been met with criticism, mostly because few consumers pay this amount unless, for instance, they lack insurance. Nonetheless, the proposal was sent last week to the White House Office of Management and Budget for review. 

Meanwhile, Johnson & Johnson is taking this idea one step further with updated ads for its Xarelto blood thinner that show not just the list price, but potential out-of-pocket costs.

Read Stat News article